Literature DB >> 25843765

Interactions between hormonal contraception and antiepileptic drugs: Clinical and mechanistic considerations.

Arne Reimers1, Eylert Brodtkorb2, Anne Sabers3.   

Abstract

Antiepileptic drugs (AEDs) and hormonal contraceptives may affect each other's metabolism and clinical efficacy. Loss of seizure control and unplanned pregnancy may occur when these compounds are used concomitantly. Although a large number of available preparations yield a plethora of possible drug combinations, most of these drug interactions are predictable and, thus, avoidable. Unfortunately, there is a substantial lack of data regarding the newer AEDs. Detailed understanding of these issues is necessary for those who prescribe AEDs and/or hormonal contraception to women with epilepsy, as well as for those who provide comprehensive care, education and counseling to them, in order to reduce the unacceptably high number of unplanned pregnancies among women with epilepsy.
Copyright © 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiepileptic drugs; Contraceptives; Drug interactions; Ethinyl estradiol; Hormonal contraception; Progestins

Mesh:

Substances:

Year:  2015        PMID: 25843765     DOI: 10.1016/j.seizure.2015.03.006

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  10 in total

1.  Antiseizure drugs and women: Challenges with contraception and pregnancy.

Authors:  Tejal Patel; Kelly A Grindrod
Journal:  Can Pharm J (Ott)       Date:  2020-09-27

2.  Antiseizure drugs for women with epilepsy: Before, during, and after pregnancy.

Authors:  Tejal Patel; Kelly Grindrod
Journal:  Can Fam Physician       Date:  2020-04       Impact factor: 3.275

3.  Inconsistent reporting of drug-drug interactions for hormonal contraception and antiepileptic drugs - Implications for reproductive health for women with epilepsy.

Authors:  Barbara M Decker; Emily K Acton; Kathryn A Davis; Allison W Willis
Journal:  Epilepsy Behav       Date:  2020-12-09       Impact factor: 2.937

Review 4.  Epilepsy: addressing the transition from pediatric to adult care.

Authors:  Seetha Rajendran; Anand Iyer
Journal:  Adolesc Health Med Ther       Date:  2016-06-27

5.  Establishing a Multidisciplinary Framework to Study Drug-Drug Interactions of Hormonal Contraceptives: An Invitation to Collaborate.

Authors:  Lawrence J Lesko; Valvanera Vozmediano; Joshua D Brown; Almut Winterstein; Ping Zhao; Jörg Lippert; Joachim Höchel; Ayyappa Chaturvedula; Annesha White; Stephan Schmidt
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-10-23

6.  The JAK1 Inhibitor Upadacitinib Has No Effect on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol: A Study in Healthy Female Subjects.

Authors:  Mohamed-Eslam F Mohamed; Sheryl Trueman; Tian Feng; Alan Friedman; Ahmed A Othman
Journal:  J Clin Pharmacol       Date:  2018-11-30       Impact factor: 3.126

7.  The Effects of Weak and Strong CYP3A Induction by Rifampicin on the Pharmacokinetics of Five Progestins and Ethinylestradiol Compared to Midazolam.

Authors:  Herbert Wiesinger; Stefan Klein; Antje Rottmann; Bettina Nowotny; Kai Riecke; Isabella Gashaw; Margarete Brudny-Klöppel; Robert Fricke; Joachim Höchel; Christian Friedrich
Journal:  Clin Pharmacol Ther       Date:  2020-05-11       Impact factor: 6.875

Review 8.  Managing Epilepsy in Women.

Authors:  Elizabeth E Gerard; Kimford J Meador
Journal:  Continuum (Minneap Minn)       Date:  2016-02

Review 9.  Contraception for women with epilepsy: counseling, choices, and concerns.

Authors:  Arne Reimers
Journal:  Open Access J Contracept       Date:  2016-04-19

Review 10.  Special Considerations in the Management of Women with Epilepsy in Reproductive Years.

Authors:  Krishna Parekh; Hannah Debra Kravets; Rebecca Spiegel
Journal:  J Pers Med       Date:  2022-01-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.